More Small Businesses are Going Bankrupt With High Interest Rates and a Shrinking Bank Loan Supply

 

 

With fluctuating interest rates and economic uncertainty, the challenges facing the banking sector and, by extension, small to medium-sized businesses, are more complex than many might think. Private debt has several implications which offer a sobering look at how interest rate changes impact not just macroeconomic stability but also loan growth and business financing. When these rates increase banks find themselves in a bind. There are no do-overs with certain things, which can risk profits.

It can end up causing a ripple effect that doesn’t just stop there. This tightening financial environment trickles down to small and medium-sized businesses, which make up the backbone of employment in the U.S. They face higher costs, challenges with loans, and see major cutbacks that can lead to bankruptcy. The situation is far more complex than businesses merely borrowing less. It’s actually an ecosystem in crisis that can’t be ignored for various reasons.

Taylor Herzog is the Founder and Chief Investment Officer at TYME Advisors. Having a background in economics and finance, Herzog specializes in dissecting complex financial systems and insights into the changing dynamics of debt, interest rates, and market behavior. His firm, TYME Advisors, consults on a range of investment strategies and economic forecasting. He contends that high interest rates and tougher chances at loans are proving to become an abysmal situation for small businesses.

Herzog’s Thoughts on the Effects of Rising Interest Rates

On Risk and Return in a Zero-Interest Rate Environment

“If you’re increasing private debt, by definition, you’re decreasing something else. So again, if our starting point was Zerg, large allocators generally were taking more risk than normal because if they have a required rate of return requirement, when bonds were paying 0 percent, you would fail your mandate. I think a critical starting point is it’s all about where you started with. So before the hiding cycle, if you’re in a Zerg land, that’s a key starting point to know where you started. And then the next variable is how fast the rates went up. Those two things is largely the seeds by which everything is behaving forward.”

Challenges for Banks

“So on the banking side, main issue is their loans don’t reprice that fast. And because they can’t reprice those loans that fast, they’re possibly at risk of not making enough money. And because of that, their loan growth is shrinking. And banks obviously live to make money by letting. And the new loans that they do offer, the loan spreads, meaning effectively, the price for those loans is expanding. So the cost of credit is going up and the supply of that credit is coming down. And a main reason for that is again, tied to rates. There are deposits, which we probably all remember being at 0 percent for 10 years. Just because rates went up to 5 percent in a year doesn’t mean they can afford to change deposits that fast because their loans don’t change that fast. So, if they don’t reprice their deposits, it leaves. And now you have a bank run. If they do reprice higher, they completely wipe out their profits. So what you end up seeing on the bank side is both the asset and liability side are decelerating.”

Rate of Change and Consequences

“And the reason why that’s important is, in this analogy, if you go from 1,000 miles an hour to zero miles an hour in two seconds, you’re a pink mist. And that’s effectively what’s happening versus taking your time over an hour, right? So that rate of change was so severe. That is why the bank side is effectively shrinking.”

Impact on Small and Medium-Sized Businesses

“And more importantly, most small and medium-sized businesses employ most of the U.S. population, and they get their debt financing from the banking system, which is small to mid-sized banks. They do not get their debt financing from capital markets, which is investors.”

On Supply and Demand Factors

“Then on the purely demand side, so that’s just all supplies, high-level. It’s supply is available, but it’s shrinking, getting more expensive. The demand side, even the loan officers at those banks are seeing lower loan demand at the same time. And you can indirectly see that by the businesses seeing their CapEx spending. That spending is slowing too. So you’re seeing this massive de-sell on the whole spectrum.”

Bankruptcy Rates and Business Closure

“And then finally, I would add to the whole demand destruction. Everything I said effectively is demand destruction, but I would argue it’s more than just a business borrowing less. The bankruptcy rate we’re seeing in businesses is rapidly accelerating. So that’s more than just, we’re gonna just borrow less. We’re putting up our, going out of business. And that’s massively accelerated since the middle of 2022, and it’s not decelerating.”

Article written by Alexandra Simon.

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More